Charles River Laboratories International Financial Ratios
NYSE: CRLHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Charles River Laboratories International ratio analysis
Charles River Laboratories International earned a net margin of -3.6% in FY 2025, down from 0.5% a year earlier. Return on equity reached -4.6%, meaning Charles River Laboratories International generated -0.05 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.68 versus 0.65 the year before, and the current ratio was 1.29.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Charles River Laboratories International financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | 930.80 | 25.64 | 22.99 | 48.58 | 34.96 | 29.97 | 24.18 | 43.09 | 23.59 |
| Price / sales | 2.51 | 2.36 | 2.93 | 2.78 | 5.25 | 4.27 | 2.82 | 2.36 | 2.80 | 2.13 |
| Price / book | 3.19 | 2.76 | 3.37 | 3.72 | 7.33 | 5.90 | 4.53 | 4.07 | 4.97 | 4.28 |
| Gross margin | — | — | — | — | — | — | — | — | 84.4% | 83.5% |
| Operating margin | 0.6% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% |
| Net margin | -3.6% | 0.5% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% |
| Free cash flow margin | 12.9% | 12.4% | 8.8% | 7.4% | 15.0% | 13.0% | 13.0% | 13.3% | 12.7% | 15.6% |
| Return on equity (ROE) | -4.6% | 0.6% | 13.2% | 16.3% | 15.4% | 17.2% | 15.4% | 17.2% | 11.8% | 18.5% |
| Return on assets (ROA) | -2.0% | 0.3% | 5.8% | 6.4% | 5.6% | 6.6% | 5.4% | 5.9% | 4.2% | 5.7% |
| Debt / equity | 0.68 | 0.65 | 0.74 | 0.91 | 1.05 | 0.93 | 1.15 | 1.26 | 1.07 | 1.45 |
| Current ratio | 1.29 | 1.41 | 1.52 | 1.32 | 1.23 | 1.43 | 1.44 | 1.61 | 1.78 | 1.53 |
| Revenue growth | -0.9% | -1.9% | 3.9% | 12.3% | 21.1% | 11.5% | 15.7% | 22.0% | 10.5% | 23.3% |
| EPS growth | -1,555.0% | -97.8% | -2.7% | 24.7% | 5.6% | 42.0% | 9.7% | 81.9% | -21.4% | 3.2% |